
ATMI LifeSciences is a leader in single-use mixing, storage, and bioreactor technology, fluoropolymer-based products, and custom-engineered, flexible packaging solutions. The business's fundamental knowledge of polymers, specially selected resins, and its clean room manufacturing experience combine to help drive optimum performance in critical disposable process operations.

ATMI LifeSciences had established recognized leadership in the area of highly-efficient technologies for cell culture development and manufacturing. The companies' innovations in process optimization, for human and veterinary vaccine, recombinant protein, stem cell and cell therapy applications, integrate perfectly with ATMI's vision and strategy. Through close collaboration with customers, the acquisition in 2010 of Artelis SA will serve to provide enabling technologies in cell culture technology to the biopharmaceutical sector, in addition to having the industry's most comprehensive single-use platform and technical support.
ATMI manufactures the BPVs in plants located in Bloomington, Minnesota and in Hoegaarden, Belgium and in. For further information on ATMI and their full line of products, visit website

Info, Communication
et Evénementiel
pour la Pharma et la Biotech
Merci pour votre organisation de la semaine dernière, il s'agissait pour moi de ma première, et j'ai trouvé cela très enrichissant.
Jean-Nicolas AUDINOT,
Lippmann
B4B-Connection Toxicité
Paris 07 octobre 2010
Interview de Nathalie Simonin, Directrice du GIPSO







Giboo a conçu et élaboré notre site internet


L'Institut de Management des Industries de la Santé (IMIS) basé à Lyon, forme et propose des profils « DOUBLE COMPETENCE Scientifique – Management & Marketing de la Santé » capable d'intégrer de grandes entreprises internationales, des PME nationales, des organismes publics, etc.